Anoro Ellipta (Umeclidinium/Vilanterol) 62.5/25mcg, 30 MDI
Anoro Ellipta (Umeclidinium/Vilanterol) is an inhaler medication for managing chronic obstructive pulmonary disease (COPD). It combines two bronchodilators to improve lung function and reduce COPD symptoms, offering convenient once-daily dosing for effective symptom control.
Anoro Ellipta (Umeclidinium/Vilanterol) is a prescription medication for chronic obstructive pulmonary disease (COPD). This inhaler combines two active ingredients, Umeclidinium and Vilanterol, which work together as bronchodilators to improve airflow in the lungs and alleviate symptoms associated with COPD.
Umeclidinium is an anticholinergic agent that helps relax the muscles around the airways, making breathing easier. Vilanterol, on the other hand, is a long-acting beta agonist (LABA) that works by relaxing the muscles in the airways to widen them, allowing more air to flow into the lungs.
Anoro Ellipta is designed for once-daily use and offers a convenient and effective treatment option for individuals with COPD. It helps reduce shortness of breath, wheezing, and coughing, enhancing overall lung function and improving the quality of life for COPD patients.
Key Benefits:
• Combines two bronchodilators in one inhaler for comprehensive COPD treatment
• Improves lung function and reduces COPD symptoms
• Once-daily dosing for convenience and adherence
• Helps manage and control COPD effectively
| Class | BRAND |
|---|---|
| Low Price | simple |
| Med Type Brand Name | 1 |
| Rx Req | 1 |